Wright Medical Group N.V. Raises Sales Guidance for the Full Year of 2018 and Provides Earnings Guidance for the Full Year of 2019
Assuming a close of the transaction in 2018, the company anticipates the acquisition to increase 2019 net sales by approximately $47 million and non-GAAP adjusted EBITDA from continuing operations by approximately $20 million, which the company anticipates will be approximately 100 basis points accretive to the company's pro forma net sales growth rate (on a constant currency basis) and approximately 100 basis points accretive to non-GAAP adjusted EBITDA margin from continuing operations.